Phenylboronic modified lipid nanocarriers mediated co-delivery of immunocytokine TRAIL and gamma-secretase inhibitor to triple negative breast cancer cells and cancer stem cells

2021 ◽  
pp. 110716
Author(s):  
Sai Kiran S.S. Pindiprolu ◽  
Harani Avasarala ◽  
SathisKumar Dinakaran
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Gamma Secretase ◽  
Secretase Inhibitor ◽  
Lipid Nanocarriers ◽  
Gamma Secretase Inhibitor

scholarly journals Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer

Oncotarget ◽  
2016 ◽  
Vol 8 (2) ◽  
pp. 2320-2328 ◽  
Author(s):  
Marzia A. Locatelli ◽  
Philippe Aftimos ◽  
E. Claire Dees ◽  
Patricia M. LoRusso ◽  
Mark D. Pegram ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Triple Negative Breast Cancer ◽  
Phase I Study ◽  
Triple Negative ◽  
Gamma Secretase ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor

scholarly journals Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells

2018 ◽  
Vol 119 (12) ◽  
pp. 1495-1507 ◽  
Author(s):  
Jun Tian ◽  
Fatmah Al Raffa ◽  
Meiou Dai ◽  
Alaa Moamer ◽  
Baharak Khadang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Breast Cancer Stem Cells
Sign in / Sign up

Export Citation Format

Share Document